Maelandsmo GM - Search Results

1

Expression of a novel factor, com1, is regulated by 1,25-dihydroxyvitamin D3 in breast cancer cells.

Bratland A, Risberg K, Maelandsmo GM, Gützkow KB, Olsen OE, Moghaddam A, Wang MY, Hansen CM, Blomhoff HK, Berg JP, Fodstad O, Ree AH. Bratland A, et al. Among authors: maelandsmo gm. Cancer Res. 2000 Oct 1;60(19):5578-83. Cancer Res. 2000. PMID: 11034106

2

Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

Flørenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS, Fodstad O. Flørenes VA, et al. Among authors: maelandsmo gm. Cancer Res. 1992 Nov 1;52(21):6088-91. Cancer Res. 1992. PMID: 1356624

3

Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas--relationship to amplification and mRNA levels of CDK4 and CCND1.

Maelandsmo GM, Berner JM, Flørenes VA, Forus A, Hovig E, Fodstad O, Myklebost O. Maelandsmo GM, et al. Br J Cancer. 1995 Aug;72(2):393-8. doi: 10.1038/bjc.1995.344. Br J Cancer. 1995. PMID: 7640224 Free PMC article.

4

The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas.

Forus A, Flørenes VA, Maelandsmo GM, Fodstad O, Myklebost O. Forus A, et al. Among authors: maelandsmo gm. Cancer Genet Cytogenet. 1994 Dec;78(2):165-71. doi: 10.1016/0165-4608(94)90085-x. Cancer Genet Cytogenet. 1994. PMID: 7828148

5

MDM2 gene amplification and transcript levels in human sarcomas: relationship to TP53 gene status.

Flørenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O, Fodstad O. Flørenes VA, et al. Among authors: maelandsmo gm. J Natl Cancer Inst. 1994 Sep 7;86(17):1297-302. doi: 10.1093/jnci/86.17.1297. J Natl Cancer Inst. 1994. PMID: 8064888

6

Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2.

Forus A, Flørenes VA, Maelandsmo GM, Meltzer PS, Fodstad O, Myklebost O. Forus A, et al. Among authors: maelandsmo gm. Cell Growth Differ. 1993 Dec;4(12):1065-70. Cell Growth Differ. 1993. PMID: 8117620

7

Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.

Maelandsmo GM, Flørenes VA, Hovig E, Oyjord T, Engebraaten O, Holm R, Børresen AL, Fodstad O. Maelandsmo GM, et al. Br J Cancer. 1996 Apr;73(8):909-16. doi: 10.1038/bjc.1996.181. Br J Cancer. 1996. PMID: 8611425 Free PMC article.

8

Regulation of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in MCF-7 cells: comparison with regulatory mechanisms of pS2 expression.

Ree AH, Maelandsmo GM, Fodstad O. Ree AH, et al. Among authors: maelandsmo gm. Clin Exp Metastasis. 1996 Sep;14(4):381-8. doi: 10.1007/BF00123397. Clin Exp Metastasis. 1996. PMID: 8878412

9

Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.

Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA. Maelandsmo GM, et al. Am J Pathol. 1996 Dec;149(6):1813-22. Am J Pathol. 1996. PMID: 8952518 Free PMC article.

10

Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme.

Maelandsmo GM, Hovig E, Skrede M, Engebraaten O, Flørenes VA, Myklebost O, Grigorian M, Lukanidin E, Scanlon KJ, Fodstad O. Maelandsmo GM, et al. Cancer Res. 1996 Dec 1;56(23):5490-8. Cancer Res. 1996. PMID: 8968106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters